Equities Research Analysts’ Updated EPS Estimates for August, 16th (BBY, DEQ, FIE, ITRK, JEN, KAZ, MOR, ORAN, ORGO, ORTX)

Share on StockTwits

Equities Research Analysts’ updated eps estimates for Friday, August 16th:

Balfour Beatty (LON:BBY) had its buy rating reissued by analysts at UBS Group AG.

Deutsche EuroShop (ETR:DEQ) was given a €30.00 ($34.88) price target by analysts at Berenberg Bank. The firm currently has a neutral rating on the stock.

Fielmann (FRA:FIE) was given a €70.00 ($81.40) target price by analysts at HSBC Holdings plc. The firm currently has a buy rating on the stock.

Intertek Group (LON:ITRK) had its price target increased by UBS Group AG from GBX 5,000 ($65.33) to GBX 5,300 ($69.25). The firm currently has a neutral rating on the stock.

Jenoptik (ETR:JEN) was given a €23.00 ($26.74) price target by analysts at HSBC Holdings plc. The firm currently has a neutral rating on the stock.

KAZ Minerals (LON:KAZ) had its buy rating reissued by analysts at UBS Group AG.

MorphoSys (ETR:MOR) was given a €81.00 ($94.19) target price by analysts at HSBC Holdings plc. The firm currently has a sell rating on the stock.

Orange (NYSE:ORAN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Orange SA provides telecommunications services. It offers a range of fixed telephony and mobile telecommunications, data transmission, Internet and multimedia, and other value-added services to consumers, businesses, and other telecommunications operators under the Orange brand worldwide. Orange SA, formerly known as France Telecom S.A., is based in Paris, France. “

Organogenesis (NASDAQ:ORGO) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. “

Orchard Therapeutics (NASDAQ:ORTX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Orchard Therapeutics plc is a biopharmaceutical company. It offers medical research, gene therapy and inherited disorder treatment services which transforms the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. Orchard Therapeutics plc is based in London, United Kingdom. “

Ovid Therapeutics (NASDAQ:OVID) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company’s product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved in developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States. “

SGL Carbon (ETR:SGL) was given a €3.50 ($4.07) target price by analysts at Berenberg Bank. The firm currently has a neutral rating on the stock.

SSE (LON:SSE) had its neutral rating reaffirmed by analysts at UBS Group AG.

Receive News & Ratings for Balfour Beatty plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balfour Beatty plc and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Equities Research Analysts’ Updated EPS Estimates for August, 16th
Equities Research Analysts’ Updated EPS Estimates for August, 16th
Analysts’ Upgrades for August, 16th
Analysts’ Upgrades for August, 16th
Insider Selling: Cadence Design Systems Inc  VP Sells $88,608.33 in Stock
Insider Selling: Cadence Design Systems Inc VP Sells $88,608.33 in Stock
Jack in the Box Inc.  EVP Sells $89,000.00 in Stock
Jack in the Box Inc. EVP Sells $89,000.00 in Stock
Insider Selling: Pan American Silver Corp.  Senior Officer Sells C$92,120.00 in Stock
Insider Selling: Pan American Silver Corp. Senior Officer Sells C$92,120.00 in Stock
Insider Selling: Adesto Technologies Corp  VP Sells $91,340.47 in Stock
Insider Selling: Adesto Technologies Corp VP Sells $91,340.47 in Stock


© 2006-2019 Ticker Report